Avricore Health Celebrates Award Recognition
Avricore Health Inc. (TSX-V: AVCR), a prominent player in pharmacy-based health technology solutions, has gained significant recognition by securing the 8th position in Deloitte Canada's 2024 Technology Fast 50™ Companies-to-Watch. The company boasts a remarkable growth rate of 2738%, showcasing its innovative impact in the health technology space.
CEO Hector Bremner expressed enthusiasm about the achievement, stating, "We are thrilled to be recognized in Deloitte's Fast 50. This award reflects our team's commitment to enhancing accessible health solutions and progressing pharmacy services across Canada." This accolade serves as a testament to their relentless pursuit of innovation and dedication to improving patient health outcomes.
Innovations in Health Technology
The Deloitte Technology Fast 50™ program acknowledges and celebrates the most innovative companies that are driving growth and transformation within the technology sector in Canada. Avricore Health’s innovative platform, HealthTab™, which enhances real-time data accessibility and health testing, stands out by empowering pharmacies to effectively support patient health.
HealthTab™ Advantage
HealthTab™ serves as a cutting-edge point-of-care testing solution that integrates advanced testing technologies with a reliable cloud-based platform. This innovative service aims to tackle critical global health issues efficiently. Through a simple finger prick, users can receive lab-accurate results right on the spot, with data reported in real time. The system supports a broad test menu with up to 23 essential biomarkers, crucial for screening and managing chronic conditions like diabetes and heart disease.
Market Insights and Demand
With the Point of Care Testing Market projected to reach an impressive $93.21 billion by the year 2030, the demand for effective health solutions like HealthTab™ underscores the essential role of pharmacies in today’s healthcare ecosystem. There is also a concerning rise in diabetes, with nearly 13.6 million Canadians expected to be diabetic or prediabetic by that same year, highlighting the need for improved diagnostics and management solutions.
Additionally, approximately one-third of Americans have pre-diabetes, further emphasizing the urgency for accessible health testing in local pharmacies. Avricore Health aims to address this prevalent issue by providing timely and actionable health information to patients.
Pioneering Pharmacy-Based Health Solutions
Avricore Health Inc. is on a mission to revolutionize pharmacy practices through innovative technologies like HealthTab™. This platform not only enhances accessibility to rapid health testing but also equips pharmacists with the necessary tools to play an essential role in primary care delivery.
Empowering Patients and Pharmacists
The unique HealthTab™ network model empowers pharmacists to take a proactive role in patient care, boosting patient engagement and control over their health while simultaneously reducing costs and waiting times. Furthermore, there are multiple potential revenue streams, including equipment leasing, consumables, and integrated health management programs.
Company Commitment to Innovation
Avricore Health’s commitment extends beyond just providing health solutions; it aims to create the world’s largest network of rapid testing devices in community pharmacies. Through its ongoing innovation and dedication, the company seeks to make actionable health information more accessible to everyone, aligning with its core mission.
Contact Avricore Health Inc.
For more information on Avricore Health and its innovative solutions, individuals can reach out directly.
Avricore Health Inc.
Hector Bremner, CEO
Phone: 604-773-8943
Email: info@avricorehealth.com
Website: www.avricorehealth.com
Frequently Asked Questions
What is Avricore Health known for?
Avricore Health is known for its innovative pharmacy-based health technology solutions, particularly through its platform HealthTab™.
What recognition has Avricore Health recently received?
The company was recognized as one of Deloitte’s 2024 Technology Fast 50™ Companies-to-Watch, securing the 8th spot.
What does HealthTab™ offer?
HealthTab™ provides point-of-care testing solutions that deliver lab-accurate health results on-site using simple blood tests.
How does HealthTab™ benefit pharmacists?
It empowers pharmacists to play a more active role in patient care and improves their ability to deliver health services directly in pharmacies.
What future goals does Avricore Health have?
Avricore Health aims to expand its network of rapid testing devices across community pharmacies to make health information easily accessible for everyone.